StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amgen (AMGN) Otezla Deal 'Highly Accretive' - Cowen
August 26, 2019 11:44 AM
Cowen analyst Yaron Werber reiterated an Outperform rating and $231.00 price target on Amgen (NASDAQ: AMGN) after the company agreed ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments